Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Receivables - Net (2024 - 2025)

Updated

Korro Bio (KRRO) reported Receivables - Net of $969,000 for Q4 2025, down 42.9% from $1.7 million a year earlier but up 18.2% from the prior quarter.

Analysis

Korro Bio (KRRO) Receivables - Net (2024 - 2025) Analysis & Trends

Dating back to Q3 2024, Korro Bio's Receivables - Net record includes 6 quarters.

  • By year, Receivables - Net came in at $1.7 million in FY2024.
  • Five-year quarterly Receivables - Net spans a low of $820,000 in Q3 2025 and a high of $10 million in Q3 2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at $820,000 (Q3 2025), $1.09 million (Q2 2025) and $1.92 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korro Bio 281.05 Mn -128.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 969,000.00
Sep 30, 2025 820,000.00
Jun 30, 2025 1.09 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 1.70 Mn
Sep 30, 2024 10.00 Mn
API Access

Korro Bio Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=KRRO&period=max&api_key=YOUR_API_KEY